Results 281 to 290 of about 397,364 (338)

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

The role of epigenetics in pulmonary fibrosis: recent advances in mechanistic insights and therapeutic implications. [PDF]

Front Mol Biosci
Huang J, Qin J, Zhu Y, Shen A.
europepmc   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu, Gui‐Qin Liu, Ya‐Ping Peng, Li‐Ling Zhang, Xian‐Jin Wang, Liang‐Chuan Chen, Yuan‐Xi Zheng, Xue‐Jun Xiang, Rui Qiao, Xian‐He Lin   +9 more
wiley   +1 more source

Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry. [PDF]

BMJ Open Respir Res
Fahim A, Loughenbury M, Stewart I, Agnew S, Almond H, Casimo L, Chaudhuri N, Fletcher SV, Haney S, Ho LP, Hodkinson C, Minnis P, Palmer E, Wilson AM, British Thoracic Society.   +14 more
europepmc   +1 more source

Polygenic Risk and Rare Variants in Endotypes of Idiopathic Pulmonary Fibrosis

Duckworth A, Jackson L, Green H, Khan A, Wang C, Condescu A, Hawkes G, Noth I, Martinez FJ, Raghu G, Newton CA, Moll M, Cho M, Gibbons M, Scotton CJ, Columbia Genomics Consortium, Kiryluk K, Garcia CK, Zhang D.   +18 more
europepmc   +1 more source

Pathogenesis and current status of the treatment of lung cancer associated with idiopathic pulmonary fibrosis. [PDF]

Respir Res
Zhang Y, Qi C, Wei Q, Li Y, Tian P.
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Ferroptosis in pulmonary fibrosis: pathogenesis and traditional Chinese medicine-driven therapeutic approaches. [PDF]

Front Cell Dev Biol
Fan X, Xu J, Gao J, Zhang J, Wang Y, Shan Y, Luo J, Fei W, Cai X.   +8 more
europepmc   +1 more source

Home‐operated ultrasound exam for detection of worsening heart failure (HOUSE‐HF)

ESC Heart Failure, EarlyView.
Abstract Aims Acute decompensated heart failure (ADHF) is associated with a high degree of morbidity and mortality. Dynamic lung ultrasound artefact called B‐lines can be obtained at the bedside and directly correlate with pulmonary vascular congestion. Obtaining patient‐performed lung ultrasound images in the outpatient setting is novel.
Stuart B. Prenner, Kevin Dougherty, Frances S. Shofer, Lee R. Goldberg, Nova Panebianco   +4 more
wiley   +1 more source

Our journey with pulmonary fibrosis: from challenges to change. [PDF]

Breathe (Sheff)
Green C, Green S, Robinson L.
europepmc   +1 more source